2021
DOI: 10.1016/j.xpro.2021.100723
|View full text |Cite
|
Sign up to set email alerts
|

Generation of hypoxia-sensing chimeric antigen receptor T cells

Abstract: Summary Exploiting hypoxia in solid malignancies to restrict expression of chimeric antigen receptors (CARs) on engineered T cells to the tumor microenvironment overcomes the risk of on-target off-tumor toxicity and minimizes tonic signaling, which promotes CAR T cell exhaustion. This protocol summarizes the synthetic biology underlying the development of a stringent oxygen-sensitive CAR for in vitro and in vivo preclinical characterization. F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The promising efficacy of this approach has been proven in vitro and in vivo, overcoming two main limitations, i.e., a more stringent control of CAR expression and a greater anti-tumor activity with no apparent on-target/off-tumor toxicity. In addition, a gene panel including VEGFA, PGK1 , CA9 , SLC2A1, and ALDOA has been proposed to select those patients who could best benefit from this promising approach [ 215 ]. He et al .…”
Section: Genome Editing and Hypoxia-response Pathwaymentioning
confidence: 99%
“…The promising efficacy of this approach has been proven in vitro and in vivo, overcoming two main limitations, i.e., a more stringent control of CAR expression and a greater anti-tumor activity with no apparent on-target/off-tumor toxicity. In addition, a gene panel including VEGFA, PGK1 , CA9 , SLC2A1, and ALDOA has been proposed to select those patients who could best benefit from this promising approach [ 215 ]. He et al .…”
Section: Genome Editing and Hypoxia-response Pathwaymentioning
confidence: 99%